Shailendra Kumar

Array ( [id] => 5678577 [patent_doc_number] => 20060183933 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Method of hydroaminating N-alkenoylcarbamates with primary aromatic amines' [patent_app_type] => utility [patent_app_number] => 11/057149 [patent_app_country] => US [patent_app_date] => 2005-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8127 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183933.pdf [firstpage_image] =>[orig_patent_app_number] => 11057149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823755 [patent_doc_number] => 20080228004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Ligand Protection for Mercaptoacetyl Triglycine' [patent_app_type] => utility [patent_app_number] => 10/585792 [patent_app_country] => US [patent_app_date] => 2005-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2001 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20080228004.pdf [firstpage_image] =>[orig_patent_app_number] => 10585792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997422 [patent_doc_number] => 20050137200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'Anthranilamides with heteroarylsulfonyl side chain, process of preparation, and use' [patent_app_type] => utility [patent_app_number] => 11/052959 [patent_app_country] => US [patent_app_date] => 2005-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13010 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137200.pdf [firstpage_image] =>[orig_patent_app_number] => 11052959 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7075399 [patent_doc_number] => 20050148667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-07 [patent_title] => 'Formoterol tartrate polymorph' [patent_app_type] => utility [patent_app_number] => 11/052268 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4819 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20050148667.pdf [firstpage_image] =>[orig_patent_app_number] => 11052268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7139101 [patent_doc_number] => 20050182276 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Process for the synthesis and crystalline form of agomelatine' [patent_app_type] => utility [patent_app_number] => 11/052630 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3826 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20050182276.pdf [firstpage_image] =>[orig_patent_app_number] => 11052630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7599646 [patent_doc_number] => 07582801 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Synthesis of [1-13C]pyruvic acid], [2-13C]pyruvic acid], [3-13C]pyruvic acid] and combinations thereof' [patent_app_type] => utility [patent_app_number] => 11/052589 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 3980 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582801.pdf [firstpage_image] =>[orig_patent_app_number] => 11052589 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136703 [patent_doc_number] => 20050181455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'Generation of combinatorial synthetic libraries and screening for novel proadhesins and nonadhesins' [patent_app_type] => utility [patent_app_number] => 11/052545 [patent_app_country] => US [patent_app_date] => 2005-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21850 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181455.pdf [firstpage_image] =>[orig_patent_app_number] => 11052545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997485 [patent_doc_number] => 20050137263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'N-(4 substituted phenyl)-anthranilic acid hydroxamate esters' [patent_app_type] => utility [patent_app_number] => 11/051142 [patent_app_country] => US [patent_app_date] => 2005-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32698 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137263.pdf [firstpage_image] =>[orig_patent_app_number] => 11051142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5085989 [patent_doc_number] => 20070276040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Peptidyl Arginine Deiminase Type IV Inhibitor' [patent_app_type] => utility [patent_app_number] => 10/588451 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11543 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0276/20070276040.pdf [firstpage_image] =>[orig_patent_app_number] => 10588451 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189143 [patent_doc_number] => 20070167452 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => 'Therapeutic amide derivatives' [patent_app_type] => utility [patent_app_number] => 10/597868 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61423 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167452.pdf [firstpage_image] =>[orig_patent_app_number] => 10597868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5310921 [patent_doc_number] => 20090018202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-15 [patent_title] => 'Modafinil compositions' [patent_app_type] => utility [patent_app_number] => 10/587086 [patent_app_country] => US [patent_app_date] => 2005-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12423 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20090018202.pdf [firstpage_image] =>[orig_patent_app_number] => 10587086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6913070 [patent_doc_number] => 20050176828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Hydrophobic polyamine analogs and methods for their use' [patent_app_type] => utility [patent_app_number] => 11/050789 [patent_app_country] => US [patent_app_date] => 2005-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 15260 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176828.pdf [firstpage_image] =>[orig_patent_app_number] => 11050789 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5005576 [patent_doc_number] => 20070203148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'Haloalkyl Carboxamides' [patent_app_type] => utility [patent_app_number] => 10/597723 [patent_app_country] => US [patent_app_date] => 2005-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18808 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20070203148.pdf [firstpage_image] =>[orig_patent_app_number] => 10597723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 638055 [patent_doc_number] => 07126010 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-24 [patent_title] => 'Benzylcycloalkyl amines as modulators of chemokine receptor activity' [patent_app_type] => utility [patent_app_number] => 11/040585 [patent_app_country] => US [patent_app_date] => 2005-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26305 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/126/07126010.pdf [firstpage_image] =>[orig_patent_app_number] => 11040585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7724471 [patent_doc_number] => 08097742 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-17 [patent_title] => 'Water-soluble, surface-functionalized nanoparticle for bioconjugation via universal silane coupling' [patent_app_type] => utility [patent_app_number] => 11/795639 [patent_app_country] => US [patent_app_date] => 2005-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 18 [patent_no_of_words] => 4281 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/097/08097742.pdf [firstpage_image] =>[orig_patent_app_number] => 11795639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699753 [patent_doc_number] => 07067665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Oxybenzamide derivatives useful for inhibiting factor Xa or Vlla' [patent_app_type] => utility [patent_app_number] => 11/039107 [patent_app_country] => US [patent_app_date] => 2005-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 57193 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067665.pdf [firstpage_image] =>[orig_patent_app_number] => 11039107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952831 [patent_doc_number] => 20050227926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors' [patent_app_type] => utility [patent_app_number] => 11/036606 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42580 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20050227926.pdf [firstpage_image] =>[orig_patent_app_number] => 11036606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 289189 [patent_doc_number] => 07547804 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-16 [patent_title] => 'Compounds, compositions, and methods employing same' [patent_app_type] => utility [patent_app_number] => 11/039275 [patent_app_country] => US [patent_app_date] => 2005-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28954 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/547/07547804.pdf [firstpage_image] =>[orig_patent_app_number] => 11039275 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 446968 [patent_doc_number] => 07253283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-07 [patent_title] => 'Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof' [patent_app_type] => utility [patent_app_number] => 11/035176 [patent_app_country] => US [patent_app_date] => 2005-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27808 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/253/07253283.pdf [firstpage_image] =>[orig_patent_app_number] => 11035176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5895503 [patent_doc_number] => 20060004042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Formulations comprising selective androgen receptor modulators' [patent_app_type] => utility [patent_app_number] => 11/029022 [patent_app_country] => US [patent_app_date] => 2005-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11153 [patent_no_of_claims] => 85 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20060004042.pdf [firstpage_image] =>[orig_patent_app_number] => 11029022 [rel_patent_id] =>[rel_patent_doc_number] =>)